Potential thrombogenic complications with the use of recombinant activated factor VII in combat trauma

Clin Appl Thromb Hemost. 2007 Apr;13(2):121-3. doi: 10.1177/1076029606298733.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Factor VII / adverse effects*
  • Factor VII / therapeutic use*
  • Humans
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Thrombosis / chemically induced*
  • Thrombosis / pathology
  • Warfare*
  • Wounds and Injuries / drug therapy*
  • Wounds and Injuries / pathology

Substances

  • Recombinant Proteins
  • Factor VII